CoChat

Structural basis of HIV-1 maturation inhibitor binding and activity

Open access

Published version of a preprint

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Abstract

HIV-1 maturation inhibitors (MIs), Bevirimat (BVM) and its analogs interfere with the catalytic cleavage of spacer peptide 1 (SP1) from the capsid protein C-terminal domain (CA CTD ), by binding to and stabilizing the CA CTD -SP1 region. MIs are under development as alternative drugs to augment current antiretroviral therapies. Although promising, their mechanism of action and associated virus resistance pathways remain poorly understood at the molecular, biochemical, and structural levels. We report atomic-resolution magic-angle-spinning NMR structures of microcrystalline assemblies of CA CTD -SP1 complexed with BVM and/or the assembly cofactor inositol hexakisphosphate (IP6). Our results reveal a mechanism by which BVM disrupts maturation, tightening the 6-helix bundle pore and quenching the motions of SP1 and the simultaneously bound IP6. In addition, BVM-resistant SP1-A1V and SP1-V7A variants exhibit distinct conformational and binding characteristics. Taken together, our study provides a structural explanation for BVM resistance as well as guidance for the design of new MIs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-023-36569-y

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 MAS NMR spectra and structure of CACTD-SP1 crystalline array. a Negative stain TEM images of CACTD-SP1 microcrystals assembled with IP6, in the presence (left) or absence of BVM (middle). Insets show the computed Fourier transforms of the images, indicating the expected hexagonal lattices and unit cell spacings. The scale bars are 100 nm. Amino acid sequence of CACTD-SP1 (right). b Representative strips of 3D and 2D MAS NMR spectra of U-13C,15N-CACTD-SP1/BVM/SO4 (white strips) and U-13C,15N-CACTD-SP1/IP6 (gray strips) crystalline arrays, illustrating sequential assignments for SP1 residues Q6-I13. The MAS NMR spectra are labeled as follows: 3D NCACX (1), 3D NCOCX (2), 2D NCACX at −79 °C (3), 2D INADEQUATE (4), 2D NCOCX at −79 °C (5), 2D CORD (6), 2D NCACX (7). No significant chemical shift perturbations were detected for the free vs. BVM- or IP6-bound samples (see Supplementary Fig. 3). c Top panel: Superposition of selected regions of 2D CORD spectra of U-13C,15N-CACTD-SP1/BVM/IP6 crystalline arrays for different mixing times: 100 ms (magenta) and 500 ms (gray). Middle panel: Superposition of selected regions of 2D NCACX (cyan) and 2D PAIN-CP (gray) spectra of U-13C,15N-CACTD-SP1/BVM/IP6 crystalline arrays. Unambiguous long-range and inter-residue correlations of SP1 residues are labeled by amino acid number in the sequence. Bottom panel: Inter-hexamer correlations are shown for the selected regions of 2D CORD (left) and CH HETCOR (middle) spectra of U-13C,15N-CACTD-SP1/BVM/IP6, and (H)NH HETCOR (right) spectra of U-13C,15N,2H-CACTD-SP1/IP6 (Buffer B). d Number of long-range and all inter-residue MAS NMR restraints per residue plotted against the residue number. e Side view of hexamer of hexamers of BVM- and IP6-bound CACTD-SP1 arrays. f Expansion of inter-hexamer (top panel) and inter-chain (bottom panel) regions showing distances obtained from MAS NMR correlation experiments. g MAS NMR structure of a single hexamer of BVM- and IP6-bound CACTD-SP1 crystalline array. The residues detected by MAS NMR and not modeled in the X-ray and cryo-EM structures13, 14 are shown in darker cyan.
Fig. 1 MAS NMR spectra and structure of CACTD-SP1 crystalline array. a Negative stain TEM images of CACTD-SP1 microcrystals assembled with IP6, in the presence (left) or absence of BVM (middle). Insets show the computed Fourier transforms of the images, indicating the expected hexagonal lattices and unit cell spacings. The scale bars are 100 nm. Amino acid sequence of CACTD-SP1 (right). b Representative strips of 3D and 2D MAS NMR spectra of U-13C,15N-CACTD-SP1/BVM/SO4 (white strips) and U-13C,15N-CACTD-SP1/IP6 (gray strips) crystalline arrays, illustrating sequential assignments for SP1 residues Q6-I13. The MAS NMR spectra are labeled as follows: 3D NCACX (1), 3D NCOCX (2), 2D NCACX at −79 °C (3), 2D INADEQUATE (4), 2D NCOCX at −79 °C (5), 2D CORD (6), 2D NCACX (7). No significant chemical shift perturbations were detected for the free vs. BVM- or IP6-bound samples (see Supplementary Fig. 3). c Top panel: Superposition of selected regions of 2D CORD spectra of U-13C,15N-CACTD-SP1/BVM/IP6 crystalline arrays for different mixing times: 100 ms (magenta) and 500 ms (gray). Middle panel: Superposition of selected regions of 2D NCACX (cyan) and 2D PAIN-CP (gray) spectra of U-13C,15N-CACTD-SP1/BVM/IP6 crystalline arrays. Unambiguous long-range and inter-residue correlations of SP1 residues are labeled by amino acid number in the sequence. Bottom panel: Inter-hexamer correlations are shown for the selected regions of 2D CORD (left) and CH HETCOR (middle) spectra of U-13C,15N-CACTD-SP1/BVM/IP6, and (H)NH HETCOR (right) spectra of U-13C,15N,2H-CACTD-SP1/IP6 (Buffer B). d Number of long-range and all inter-residue MAS NMR restraints per residue plotted against the residue number. e Side view of hexamer of hexamers of BVM- and IP6-bound CACTD-SP1 arrays. f Expansion of inter-hexamer (top panel) and inter-chain (bottom panel) regions showing distances obtained from MAS NMR correlation experiments. g MAS NMR structure of a single hexamer of BVM- and IP6-bound CACTD-SP1 crystalline array. The residues detected by MAS NMR and not modeled in the X-ray and cryo-EM structures13, 14 are shown in darker cyan.CC BY · PubMed Central
Fig. 2 MAS NMR structure of BVM- and IP6-bound CACTD-SP1. a Superposition of selected regions of 2D HC CP HETCOR spectra (top three panels) and 2D dREDOR-HETCOR spectra (bottom panel) of U-13C,15N,2H-CACTD-SP1/BVM/IP6 (gray) and U-13C,15N,2H-CACTD-SP1/IP6 (cyan) assemblies. The BVM and IP6 1H atoms and CACTD-SP1 residues with 13C atoms are indicated outside and inside each spectrum, respectively. b Chemical identity of IP6 and BVM molecules. The IP6 and BVM protons interacting with CACTD-SP1 residues are shown in cyan and gray, respectively. c Top panel: IP6 binding mode in the hexamer of CACTD-SP1/IP6 assemblies (dark cyan, PDB: 7R7Q, this work). Bottom panel: IP6 and BVM binding modes in the hexamer of CACTD-SP1/BVM/IP6 assemblies (gray, PDB: 7R7P, this work). Residues interacting with IP6 or BVM are shown as sticks. d Superposition of MAS NMR structure of CACTD-SP1/BVM/IP6 and CACTD-SP1/IP6 shown in side view (top) and top view (bottom). BVM binding induces major structural rearrangements of the SP1 helices, resulting in the tightening of the pore and quenching the motions of the simultaneously bound IP6. Residues colored in magenta give rise to high intensity peaks, corresponding to intra- and inter-residue correlations upon BVM binding.
Fig. 2 MAS NMR structure of BVM- and IP6-bound CACTD-SP1. a Superposition of selected regions of 2D HC CP HETCOR spectra (top three panels) and 2D dREDOR-HETCOR spectra (bottom panel) of U-13C,15N,2H-CACTD-SP1/BVM/IP6 (gray) and U-13C,15N,2H-CACTD-SP1/IP6 (cyan) assemblies. The BVM and IP6 1H atoms and CACTD-SP1 residues with 13C atoms are indicated outside and inside each spectrum, respectively. b Chemical identity of IP6 and BVM molecules. The IP6 and BVM protons interacting with CACTD-SP1 residues are shown in cyan and gray, respectively. c Top panel: IP6 binding mode in the hexamer of CACTD-SP1/IP6 assemblies (dark cyan, PDB: 7R7Q, this work). Bottom panel: IP6 and BVM binding modes in the hexamer of CACTD-SP1/BVM/IP6 assemblies (gray, PDB: 7R7P, this work). Residues interacting with IP6 or BVM are shown as sticks. d Superposition of MAS NMR structure of CACTD-SP1/BVM/IP6 and CACTD-SP1/IP6 shown in side view (top) and top view (bottom). BVM binding induces major structural rearrangements of the SP1 helices, resulting in the tightening of the pore and quenching the motions of the simultaneously bound IP6. Residues colored in magenta give rise to high intensity peaks, corresponding to intra- and inter-residue correlations upon BVM binding.CC BY · PubMed Central
Fig. 3 Effect of BVM binding on wild-type (WT) and the SP1-A1V and SP1-V7A variants. a Superposition of selected regions of 2D HC CP HETCOR spectra of U-13C,15N,2H-CACTD-SP1/BVM/IP6 (gray) and U-13C,15N,2H-CACTD-SP1/IP6 (cyan) (top panel); U-13C,15N,2H-CACTD-SP1-V7A/BVM/IP6 (magenta) and U-13C,15N,2H-CACTD-SP1-V7A/IP6 (light green) (middle panel); and U-13C,15N,2H-CACTD-SP1-A1V/BVM/IP6 (orange) and U-13C,15N,2H-CACTD-SP1-A1V/IP6 (purple) (bottom panel). Intra- and inter-residue correlations arising upon BVM binding only in WT CACTD-SP1 but not in CACTD-SP1-V7A or CACTD-SP1-A1V are labeled. Residues showing multiple conformers are denoted with a, b, c. b Superposition of selected regions of 2D CORD spectra of U-13C,15N,2H-CACTD-SP1/BVM/IP6 (gray) and U-13C,15N,2H-CACTD-SP1/IP6 (cyan) (top panel); U-13C,15N,2H-CACTD-SP1-V7A/BVM/IP6 (magenta) and U-13C,15N,2H-CACTD-SP1-V7A/IP6 (light green) (middle panel); and U-13C,15N,2H-CACTD-SP1-A1V/BVM/IP6 (orange) and U-13C,15N,2H-CACTD-SP1-A1V/IP6 (purple) (bottom panel). Intra-residue cross-peaks exhibiting intensity or chemical shift changes due to BVM binding in WT CACTD-SP1 are labeled. The corresponding correlations are either absent or exhibit small chemical shift perturbations upon BVM binding to CACTD-SP1-V7A/BVM/IP6 and in CACTD-SP1-A1V/BVM/IP6. c Top & middle: 31P direct polarization (DP, top) and cross polarization (CP, middle) spectra of U-13C,15N,2H-CACTD-SP1/BVM/IP6 (gray), U-13C,15N,2H-CACTD-SP1/IP6 (cyan), U-13C,15N,2H-CACTD-SP1-V7A/BVM/IP6 (magenta), U-13C,15N,2H-CACTD-SP1-V7A/IP6 (light green), U-13C,15N,2H-CACTD-SP1-A1V/BVM/IP6 (orange), and U-13C,15N,2H-CACTD-SP1-A1V/IP6 (purple). Bottom: Overlay of 2D (H)PH HETCOR spectra of U-13C,15N,2H-CACTD-SP1/BVM/IP6 (gray) and U-13C,15N,2H-CACTD-SP1-V7A/BVM/IP6 (magenta) (left). Tilted orientation of IP6 in WT CACTD-SP1/BVM/IP6 (middle) (PDB: 7R7P, this work). Horizontal orientation of IP6 in CACTD-SP1-V7A/BVM/IP6 (right). d Chemical shift perturbations induced by BVM binding in WT CACTD-SP1 (top), CACTD-SP1-V7A (middle), and CACTD-SP1-A1V (bottom), plotted against residue number. e CACTD-SP1/BVM/IP6 structure with residues exhibiting unique CSPs, intra- and inter-residue correlations, and enhanced peak intensities upon BVM binding to WT CACTD-SP1 shown in blue.
Fig. 3 Effect of BVM binding on wild-type (WT) and the SP1-A1V and SP1-V7A variants. a Superposition of selected regions of 2D HC CP HETCOR spectra of U-13C,15N,2H-CACTD-SP1/BVM/IP6 (gray) and U-13C,15N,2H-CACTD-SP1/IP6 (cyan) (top panel); U-13C,15N,2H-CACTD-SP1-V7A/BVM/IP6 (magenta) and U-13C,15N,2H-CACTD-SP1-V7A/IP6 (light green) (middle panel); and U-13C,15N,2H-CACTD-SP1-A1V/BVM/IP6 (orange) and U-13C,15N,2H-CACTD-SP1-A1V/IP6 (purple) (bottom panel). Intra- and inter-residue correlations arising upon BVM binding only in WT CACTD-SP1 but not in CACTD-SP1-V7A or CACTD-SP1-A1V are labeled. Residues showing multiple conformers are denoted with a, b, c. b Superposition of selected regions of 2D CORD spectra of U-13C,15N,2H-CACTD-SP1/BVM/IP6 (gray) and U-13C,15N,2H-CACTD-SP1/IP6 (cyan) (top panel); U-13C,15N,2H-CACTD-SP1-V7A/BVM/IP6 (magenta) and U-13C,15N,2H-CACTD-SP1-V7A/IP6 (light green) (middle panel); and U-13C,15N,2H-CACTD-SP1-A1V/BVM/IP6 (orange) and U-13C,15N,2H-CACTD-SP1-A1V/IP6 (purple) (bottom panel). Intra-residue cross-peaks exhibiting intensity or chemical shift changes due to BVM binding in WT CACTD-SP1 are labeled. The corresponding correlations are either absent or exhibit small chemical shift perturbations upon BVM binding to CACTD-SP1-V7A/BVM/IP6 and in CACTD-SP1-A1V/BVM/IP6. c Top & middle: 31P direct polarization (DP, top) and cross polarization (CP, middle) spectra of U-13C,15N,2H-CACTD-SP1/BVM/IP6 (gray), U-13C,15N,2H-CACTD-SP1/IP6 (cyan), U-13C,15N,2H-CACTD-SP1-V7A/BVM/IP6 (magenta), U-13C,15N,2H-CACTD-SP1-V7A/IP6 (light green), U-13C,15N,2H-CACTD-SP1-A1V/BVM/IP6 (orange), and U-13C,15N,2H-CACTD-SP1-A1V/IP6 (purple). Bottom: Overlay of 2D (H)PH HETCOR spectra of U-13C,15N,2H-CACTD-SP1/BVM/IP6 (gray) and U-13C,15N,2H-CACTD-SP1-V7A/BVM/IP6 (magenta) (left). Tilted orientation of IP6 in WT CACTD-SP1/BVM/IP6 (middle) (PDB: 7R7P, this work). Horizontal orientation of IP6 in CACTD-SP1-V7A/BVM/IP6 (right). d Chemical shift perturbations induced by BVM binding in WT CACTD-SP1 (top), CACTD-SP1-V7A (middle), and CACTD-SP1-A1V (bottom), plotted against residue number. e CACTD-SP1/BVM/IP6 structure with residues exhibiting unique CSPs, intra- and inter-residue correlations, and enhanced peak intensities upon BVM binding to WT CACTD-SP1 shown in blue.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 55 references

Cited by

See all 28

Metadata

Authors
Sarkar, S., Zadrozny, K. K., Zadorozhnyi, R., Russell, R. W., Quinn, C. M., Kleinpeter, A., Ablan, S., Meshkin, H., Perilla, J. R., Freed, E. O., Ganser-Pornillos, B. K., Pornillos, O., Gronenborn, A. M., & Polenova, T.
Affiliations
  • University of Pittsburgh (US)
  • University of Virginia (US)
  • University of Delaware (US)
  • National Cancer Institute (US)
Corresponding author
  • Pornillos, Owen
  • Gronenborn, Angela M.
  • Polenova, Tatyana
Venue
Nature Communications
Published
2023-03-04
Volume
14
Issue
1
Pages
1237-1237
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4323050140
Cited by
28
References
55
Citations by year
2026: 5 · 2025: 8 · 2024: 8 · 2023: 6
FWCI
3.54
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health (P50-AI1504817, 1U54AI170791, R01-AI129678)
  • U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (P30-GM110758, P20GM104316)
  • National Science Foundation (CHE0959496)
  • U.S. Department of Health & Human Services | National Institutes of Health (R01AI157843)
Topics
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
  • Physical Sciences › Chemistry › Spectroscopy › Advanced NMR Techniques and Applications
Keywords
HIV-1 maturation inhibitors, bevirimat, phytic acid, drug resistance, magic angle spinning NMR, protein complex structure, antiretroviral drug design
MeSH terms
Capsid, Catalysis, Succinates, Triterpenes, HIV-1, Capsid Proteins, Pentacyclic Triterpenes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Structural basis of HIV-1 maturation inhibitor binding and activity. https://app.cochat.ai/papers/10.1038/s41467-023-36569-y
The paper
Sarkar, S., Zadrozny, K. K., Zadorozhnyi, R., Russell, R. W., Quinn, C. M., Kleinpeter, A., Ablan, S., Meshkin, H., Perilla, J. R., Freed, E. O., Ganser-Pornillos, B. K., Pornillos, O., Gronenborn, A. M., & Polenova, T. (2023). Structural basis of HIV-1 maturation inhibitor binding and activity. Nature Communications. https://doi.org/10.1038/s41467-023-36569-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.